Values First Advisors Inc. Buys Shares of 732 Cabot Co. (NYSE:CBT)

Values First Advisors Inc. purchased a new position in shares of Cabot Co. (NYSE:CBT) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund purchased 732 shares of the specialty chemicals company’s stock, valued at approximately $82,000.

A number of other institutional investors and hedge funds have also modified their holdings of CBT. Wolff Wiese Magana LLC acquired a new stake in Cabot during the 3rd quarter worth $25,000. CWM LLC boosted its position in shares of Cabot by 60.6% in the 2nd quarter. CWM LLC now owns 416 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 157 shares during the last quarter. UMB Bank n.a. grew its stake in shares of Cabot by 53.9% during the third quarter. UMB Bank n.a. now owns 371 shares of the specialty chemicals company’s stock worth $41,000 after purchasing an additional 130 shares during the period. EverSource Wealth Advisors LLC increased its holdings in Cabot by 33.4% in the second quarter. EverSource Wealth Advisors LLC now owns 475 shares of the specialty chemicals company’s stock valued at $48,000 after purchasing an additional 119 shares during the last quarter. Finally, 1620 Investment Advisors Inc. acquired a new position in Cabot in the second quarter valued at about $49,000. 93.18% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have recently issued reports on CBT shares. JPMorgan Chase & Co. boosted their target price on Cabot from $95.00 to $105.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 7th. UBS Group decreased their price objective on shares of Cabot from $103.00 to $98.00 and set a “neutral” rating for the company in a report on Tuesday, August 6th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $101.75.

Insider Activity at Cabot

In other Cabot news, CEO Sean D. Keohane sold 25,617 shares of Cabot stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total value of $2,601,406.35. Following the sale, the chief executive officer now owns 331,174 shares of the company’s stock, valued at $33,630,719.70. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, CEO Sean D. Keohane sold 25,617 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the completion of the transaction, the chief executive officer now directly owns 331,174 shares of the company’s stock, valued at $33,630,719.70. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Erica Mclaughlin sold 23,274 shares of Cabot stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $99.79, for a total value of $2,322,512.46. Following the completion of the sale, the chief financial officer now directly owns 59,814 shares in the company, valued at approximately $5,968,839.06. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 71,939 shares of company stock valued at $7,308,812. 3.07% of the stock is owned by corporate insiders.

Cabot Trading Down 1.0 %

NYSE:CBT opened at $109.26 on Friday. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.22 and a quick ratio of 1.45. The business’s 50-day simple moving average is $107.40 and its 200-day simple moving average is $100.27. Cabot Co. has a fifty-two week low of $65.10 and a fifty-two week high of $117.14. The stock has a market capitalization of $6.04 billion, a PE ratio of 13.83, a price-to-earnings-growth ratio of 0.93 and a beta of 1.19.

Cabot (NYSE:CBT) last announced its earnings results on Monday, August 5th. The specialty chemicals company reported $1.92 EPS for the quarter, topping the consensus estimate of $1.72 by $0.20. Cabot had a net margin of 12.05% and a return on equity of 26.99%. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1 billion. During the same period last year, the company posted $1.42 EPS. The business’s quarterly revenue was up 5.0% on a year-over-year basis. Sell-side analysts expect that Cabot Co. will post 7.07 earnings per share for the current fiscal year.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.